Free Trial

State of Wyoming Lowers Stake in American Healthcare REIT, Inc. (NYSE:AHR)

American Healthcare REIT logo with Finance background

State of Wyoming cut its position in American Healthcare REIT, Inc. (NYSE:AHR - Free Report) by 63.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 5,900 shares of the company's stock after selling 10,185 shares during the quarter. State of Wyoming's holdings in American Healthcare REIT were worth $168,000 at the end of the most recent quarter.

A number of other large investors have also recently made changes to their positions in the company. Vanguard Group Inc. lifted its position in American Healthcare REIT by 94.8% during the 4th quarter. Vanguard Group Inc. now owns 15,357,331 shares of the company's stock worth $436,455,000 after acquiring an additional 7,474,374 shares during the period. Principal Financial Group Inc. lifted its position in American Healthcare REIT by 29.0% during the 4th quarter. Principal Financial Group Inc. now owns 12,238,887 shares of the company's stock worth $347,831,000 after acquiring an additional 2,750,137 shares during the period. Cbre Investment Management Listed Real Assets LLC acquired a new stake in American Healthcare REIT during the 4th quarter worth approximately $33,838,000. Geode Capital Management LLC lifted its position in American Healthcare REIT by 46.4% during the 4th quarter. Geode Capital Management LLC now owns 3,699,793 shares of the company's stock worth $105,171,000 after acquiring an additional 1,172,670 shares during the period. Finally, Northern Trust Corp lifted its position in American Healthcare REIT by 99.0% during the 4th quarter. Northern Trust Corp now owns 1,732,882 shares of the company's stock worth $49,249,000 after acquiring an additional 861,882 shares during the period. 16.68% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

AHR has been the subject of a number of recent research reports. Jefferies Financial Group initiated coverage on American Healthcare REIT in a research report on Monday, April 28th. They set a "buy" rating and a $37.00 price objective for the company. Royal Bank of Canada reaffirmed an "outperform" rating and set a $34.00 price objective on shares of American Healthcare REIT in a research report on Wednesday, March 19th. Citigroup reaffirmed an "outperform" rating on shares of American Healthcare REIT in a research report on Tuesday, March 4th. Morgan Stanley raised their price target on American Healthcare REIT from $37.00 to $45.00 and gave the company an "overweight" rating in a report on Tuesday, May 20th. Finally, KeyCorp reduced their price target on American Healthcare REIT from $35.00 to $34.00 and set an "overweight" rating for the company in a report on Monday, March 31st. Eight investment analysts have rated the stock with a buy rating, Based on data from MarketBeat, the company currently has a consensus rating of "Buy" and an average price target of $35.00.

Read Our Latest Stock Analysis on AHR

American Healthcare REIT Price Performance

Shares of AHR traded up $0.01 during mid-day trading on Thursday, hitting $34.72. The company's stock had a trading volume of 683,414 shares, compared to its average volume of 1,854,061. The company has a current ratio of 0.37, a quick ratio of 0.37 and a debt-to-equity ratio of 0.59. The firm has a 50-day simple moving average of $31.61 and a 200 day simple moving average of $29.55. The firm has a market capitalization of $5.54 billion, a P/E ratio of -72.38, a P/E/G ratio of 1.57 and a beta of 1.40. American Healthcare REIT, Inc. has a 1-year low of $13.89 and a 1-year high of $35.97.

American Healthcare REIT (NYSE:AHR - Get Free Report) last released its quarterly earnings data on Thursday, May 8th. The company reported $0.38 earnings per share for the quarter, beating the consensus estimate of $0.37 by $0.01. The firm had revenue of $540.60 million during the quarter, compared to the consensus estimate of $542.32 million. American Healthcare REIT had a negative return on equity of 1.87% and a negative net margin of 1.84%. American Healthcare REIT's quarterly revenue was up 8.2% on a year-over-year basis. During the same period last year, the business posted $0.30 EPS. Analysts predict that American Healthcare REIT, Inc. will post 1.41 EPS for the current fiscal year.

American Healthcare REIT Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Thursday, April 17th. Shareholders of record on Monday, March 31st were given a dividend of $0.25 per share. The ex-dividend date was Monday, March 31st. This represents a $1.00 dividend on an annualized basis and a yield of 2.88%. American Healthcare REIT's payout ratio is -370.37%.

American Healthcare REIT Company Profile

(Free Report)

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.

Recommended Stories

Institutional Ownership by Quarter for American Healthcare REIT (NYSE:AHR)

Should You Invest $1,000 in American Healthcare REIT Right Now?

Before you consider American Healthcare REIT, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and American Healthcare REIT wasn't on the list.

While American Healthcare REIT currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings Preview: HUGE Stock Move Ahead
These 5 Small Stocks Could Deliver Huge Returns
ACT FAST! Congress Is POURING Into This Stock

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines